Luminopia
Company

Last deal

$16M

Amount

Series A

Stage

27.06.2023

Date

3

all rounds

$37.22M

Total amount

date founded

Financing round

General

About Company
Luminopia develops digital therapeutics for neuro-visual disorders.

Industry

Sector :

Subsector :

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Their lead product, Luminopia One, uses virtual reality to treat amblyopia, or lazy eye, by encouraging weaker eye usage and proper binocular fusion. The company is an Innovation Partner of Boston Children’s Hospital and is pioneering a new class of rigorously developed digital therapeutics to improve the lives of children and families.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Amblyotech

Amblyotech

Amblyotech develops active and passive video therapies to treat amblyopia.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Atlanta, GA, USA

total rounds

2

total raised

$602.2K
Dopavision

Dopavision

Dopavision is a therapeutic company developing a digital therapeutic for myopia.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Therapeutics, Biotechnology

Location

Berlin, Germany

total rounds

2

total raised

$15.57M
Ababax.Health

Ababax.Health

Ababax is a Deeptech company developing Digital Drugs™ for non-invasive brain stimulation.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Information Technology

Location

Berlin, Germany

count Of Investments

1
MindMaze

MindMaze

MindMaze is a digital neurotherapeutic platform that provides assessments and therapeutics to treat and rehab patients..

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Augmented Reality, Virtual Reality

Location

Lausanne, Switzerland

total rounds

10

total raised

$340.6M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$37.22M

Money Raised

Their latest funding was raised on 27.06.2023. Their latest investor The Vertical Group. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
11.11.2022
4
$5.7M
19.10.2022
$4.07M
U.S. Venture Partners

U.S. Venture Partners

US Venture Partners is a venture capital firm that invests in early-stage ventures in information technology and healthcare.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Menlo Park, CA, USA

count Of Investments

460

count Of Exists

154
Shangbay Capital

Shangbay Capital

ShangBay Capital is a venture capital firm that invests in the U.S. medical devices technology, biotech, and mobile healthcare sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Palo Alto, CA, USA

count Of Investments

35

count Of Exists

1
Co-Investors
Investors
9
2

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
The Vertical Group

The Vertical Group

The Vertical Group is a venture capital firm focused on medical technology and biotechnology.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Financial Services, Medical

Location

Basking Ridge, Bernards, NJ 07920, USA

count Of Investments

51

count Of Exists

18
U.S. Venture Partners

U.S. Venture Partners

US Venture Partners is a venture capital firm that invests in early-stage ventures in information technology and healthcare.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Menlo Park, CA, USA

count Of Investments

460

count Of Exists

154
Casey Tansey

Casey Tansey

Casey Tansey joined USVP as a general partner in April 2005. A veteran of the medical device industry, Casey brings over 25 years of entrepreneurial, early-stage medical device and seasoned operating experience to USVP. Casey's extensive operations experience brings more to the table than strategic counsel -- he adds empathy to that mix. Casey's investment strategy is a lot like his strategy as a CEO: identify unmet clinical needs where patients are in need of new and improved products and services. At USVP, Casey focuses on the trend toward the miniaturization of devices and the development of minimally-invasive technologies that promise innovations in the delivery of medical products and services, especially in cardiovascular products, orthopedics, spinal care and neurology. Casey's passion is to strive for delivery of medical services with less trauma to the patient and improved quality of life. Innovations shaping this trend include minimally-invasive technologies. During his tenure as CEO and President of Epicor Medical from 2001 to 2004, Casey, along with a dedicated team, pioneered a minimally-invasive treatment for atrial fibrillation and transformed the company into a recognized market leader, and he led Epicor's acquisition by St. Jude Medical. Prior to Epicor, Casey was CEO and President of Heartport, a public company that helped pioneer minimally-invasive cardiac surgery which is now a Johnson & Johnson company. Before that, he was with Baxter Edward's Cardiovascular Division for nearly ten years, holding various sales and marketing positions. During his tenure at Baxter, Casey was involved in launching innovative heart valve products that have grown to be the market leaders. Casey serves on the Board of Directors for ApniCure, CardioKinetix, Devax, Inspire Medical, Intersect ENT, Intuity Medical, ReShape Medical, and SentreHEART. In addition, he served as the Chairman of the Board of Directors of the World Heart Foundation, an organization dedicated to advancing humanitarian efforts in heart surgery worldwide through education and collaboration. Casey holds a B.S. and M.B.A. from the College of Notre Dame in Belmont, CA. Casey has served on the boards of Epicor Medical and Heartport.

current job

U.S. Venture Partners
U.S. Venture Partners
Shangbay Capital

Shangbay Capital

ShangBay Capital is a venture capital firm that invests in the U.S. medical devices technology, biotech, and mobile healthcare sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Palo Alto, CA, USA

count Of Investments

35

count Of Exists

1
William Dai

William Dai

William Dai serves as the Founding Managing Partner at ShangBay Capital.

current job

Shangbay Capital
Shangbay Capital

People

Founders
3
Dean Travers
Dean Travers

Dean Travers

Dean Travers is the Co-Founder & CEO at Odin.

current job

Odin
Odin

organization founded

2

Dean Travers

Scott Xiao
Scott Xiao

Scott Xiao

Scott Xiao is the Co-Founder & CEO at Luminopia.

current job

Luminopia
Luminopia

organization founded

1

Scott Xiao

Alex Wendland
Alex Wendland

Alex Wendland

Alex Wendland is the Software Engineer at Pinwheel.

current job

Pinwheel
Pinwheel

organization founded

1

Alex Wendland

Employee Profiles
6
Hank Wu

Hank Wu

COO

Endri Angjeli

Endri Angjeli

VP of Clinical Development

Endri Angjeli

Clinical development lead

Dean Travers

Dean Travers

Co-Founder & Chairman

Scott Xiao

Scott Xiao

Co-Founder & CEO

Activity

Recent News
1